Table 1. Comorbidities and current medication in obese and non-obese participants.
| Obese (n = 117) | Non-obese (n = 83) | p value (Fisher's exact test) | |
|---|---|---|---|
| Comorbidities | |||
| Hypertension | 55 | 3 | < 0.001 |
| Arthrosis | 35 | 0 | NA |
| Diabetes mellitus | 28 | 0 | NA |
| Hypothyreosis | 24 | 4 | = 0.002 |
| Asthma | 15 | 3 | = 0.026 |
| Cardiovascular disease | 12 | 0 | NA |
| Sleep apnea | 7 | 0 | NA |
| Steatosis hepatis | 6 | 0 | NA |
| Gastroesophageal reflux disease | 6 | 0 | NA |
| Atopic disease | 5 | 2 | = 0.702 |
| Glaucoma | 4 | 0 | NA |
| Articular gout | 2 | 0 | NA |
| Polycystic ovary syndrome | 1 | 0 | NA |
| Current medication | |||
| Antihypertensives | 50 | 3 | < 0.001 |
| Beta blockers | 18 | 2 | = 0.003 |
| ACE Inhibitoren | 20 | 1 | < 0.001 |
| Diuretics | 25 | 0 | NA |
| Calcium antagonists | 5 | 0 | NA |
| AT1 antagonists | 13 | 0 | NA |
| Alpha2 agonist | 3 | 0 | NA |
| Alpha1 blocker | 2 | 0 | NA |
| Oral antidiabetics | 24 | 0 | NA |
| Thyroid hormones | 16 | 4 | = 0.052 |
| Contraceptives | 11 | 9 | = 0.813 |
| Uricostatics | 10 | 0 | NA |
| NSAID | 8 | 0 | NA |
| Insulin | 7 | 0 | NA |
| Proton pump inhibitors | 6 | 0 | NA |
| Statins | 4 | 0 | NA |
| Bronchodilators | 2 | 1 | = 1.000 |
| Nitrates | 2 | 0 | NA |
| Glucocorticoids | 1 | 1 | = 1.000 |
| Vitamin K antagonists | 1 | 0 | NA |
| Antihistaminica | 1 | 0 | NA |
| Antirheumatics | 1 | 0 | NA |
| Opioids | 1 | 0 | NA |